Tamtam Try Tamtam free
Celanese logo

Celanese account plan

Chemical material solutions production

At a glance

Celanese is a global chemical and specialty materials company with FY2025 net sales of $9,544 million and 11,434 employees.

Celanese, headquartered in Irving, Texas and listed on the NYSE as CE, produces engineered polymers and acetyl products used in automotive, medical, electronics, construction, paints and coatings, packaging and many other industries. It runs 51 global production facilities plus 20 strategic affiliate production facilities, mainly in North America, Europe and Asia. FY2025 net sales were $9,544 million, down 7%, with a net loss attributable to Celanese of $(1,165) million driven by $1,513 million of asset impairment losses. It had 11,434 employees at December 31, 2025, and total debt of $12.6 billion makes deleveraging its overriding priority.

Business units

Strategic priorities

Deleveraging
Total debt cut to $11,545 million at September 30, 2026 from $12,598 million at end-2025; net debt to operating EBITDA expected at about 4.7x at end-2026, with buybacks paused and the dividend about 95% below pre-2025 levels.
Free cash flow
2026 free cash flow guidance raised to $750-800 million, with more than $1.5 billion expected across 2025 and 2026; the CFO is confident in a similar range for 2027.
Divestitures
Target of about $1 billion of proceeds through end-2027; the Micromax sale and the Nutrinova stake sale bring cumulative proceeds to nearly two-thirds of it.
Grow & Fortify in Engineered Materials
About 30 priority subsegments in AI infrastructure, medical devices and vehicle electrification; AI infrastructure is sized at a serviceable addressable market of over $1.0 billion by 2030.
Cost and footprint
Ulsan, Lanaken and nylon 6,6 actions deliver over $50 million of annualized fixed-cost savings, and a $150 million gross productivity target aims to offset 2027 inflation.

Latest results

In Q3 2026 net sales rose 6% to $2,556 million, with price up 10% and volume down 4%. Operating profit was $198 million against a $(1,275) million loss a year earlier, when Engineered Materials booked impairments, and diluted EPS was $0.67; adjusted EPS was $1.65, up 23%. Engineered Materials net sales slipped 1.2% to $1,368 million after the Micromax sale, while Acetyl Chain net sales rose 13.9% on regional supply dislocation. Nine-month net sales were $7,645 million, up 4%. Celanese raised its 2026 outlook to adjusted EPS of about $6.00-6.25 and free cash flow of $750-800 million.

Investments and deals

Capital expenditure
Capex of $343 million in 2025 and about $300-350 million guided for 2026, focused on maintenance and productivity.
Nanjing LCP plant and compounding
The Nanjing LCP facility is on schedule for completion by the end of 2026 with production in 2027; specialty compounding in Europe and medical-grade compounding in Asia are to be commercialized in H1 2027.
Frankfurt VAE expansion
The Frankfurt VAE emulsion expansion was completed and started production in Q3 2026.
Micromax and Nutrinova sales
Micromax sold to Element Solutions for $492 million (closed February 2, 2026); agreement of August 31, 2026 to sell 19% of Nutrinova to Mitsui for about $152 million.
Site closures
Lanaken (Belgium) acetate tow manufacturing ceased in Q3 2026, worth about $20 to $25 million of annualized savings; closures at Sakra (Singapore) and Ulsan (South Korea).

Challenges and risks

High leverage and covenants
Total debt of $12.6 billion at end-2025; step-downs of the leverage covenant on the $1.75 billion U.S. revolving facility from Q1 2026 were flagged as a compliance risk without mitigation.
Weak end markets
Demand stayed weak in automotive, paints, coatings and construction; auto volumes are down in 2026, mainly on lower China builds.
Raw material and energy costs
Higher ethylene and methanol costs, European energy costs and Rhine River logistics disruptions weighed on results in 2026.
Asian competition and overcapacity
New capacity added in Asia brings more competition on standard grades, and acetate tow market conditions have been challenging.
Impairments
$1,513 million of asset impairment losses in FY2025; further goodwill and intangible impairments are listed as possible.

What leadership says

“Together, medical and electronics represent less than one-fifth of EM sales, yet contribute nearly 30 percent to earnings.”

Scott Richardson, President and Chief Executive Officer · Q3 2026 earnings prepared comments, November 2, 2026

“The specialty polymer demand for an AI server is approximately three times greater than for a conventional server”

Scott Richardson, President and Chief Executive Officer · Q2 2026 earnings prepared comments, August 4, 2026

“we are seeing kind of a generational spike in demand coming from kind of the global data center build out around AI”

Scott Richardson, President and Chief Executive Officer · Q3 2026 earnings call, November 3, 2026

“We are confident in this 7 to 800 range for next year.”

Chuck Kyrish, SVP and Chief Financial Officer · Q3 2026 earnings call, November 3, 2026, on 2027 free cash flow

Where a supplier can help

Manufacturing productivity and AI
Tied to the $150 million gross productivity target: AI-based tools for raw material efficiency, energy and maintenance that the CEO calls next generation productivity.
Energy and raw material cost management
Tied to the raw material and energy cost challenge: procurement analytics, energy efficiency and supply chain agility.
Electronics and medical application development
Tied to the Grow & Fortify priority: partners and tooling that help commercialize polymers for AI servers, connectors and drug delivery devices.
Divestiture and transaction support
Tied to the $1 billion divestiture target: advisory and separation services for joint-venture transactions.
Working capital and cash flow
Tied to the free cash flow and deleveraging priorities: inventory and receivables optimization, as inventories remain elevated.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Celanese?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Celanese

What does Celanese do?

Celanese makes engineered polymers (Engineered Materials) and acetyl products (Acetyl Chain) used in automotive, medical, electronics, construction, coatings and other industries.

What is Celanese's revenue?

FY2025 net sales were $9,544 million, down 7%. Q3 2026 net sales were $2,556 million, up 6%.

How many employees does Celanese have?

11,434 employees at December 31, 2025.

What is Celanese's strategy?

Deleveraging through free cash flow, cost cuts and about $1 billion of divestitures by end-2027, while growing Engineered Materials in AI infrastructure, medical devices and vehicle electrification.

Who leads Celanese?

Scott A. Richardson has been President and CEO since January 1, 2025; Chuck B. Kyrish is SVP and CFO.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)